Bio-Thera Solutions and SteinCares have entered into a new licensing agreement for marketing two biosimilars as per which SteinCares gains exclusive distribution and marketing rights to Bio-Thera’s products across Brazil and the rest of the region
Under the agreement, Bio-Thera will handle the biosimilars’ development & regulatory submissions with the US FDA & the EMA to support regulatory filings across the LATAM region. It will also handle the commercial supply from its manufacturing facilities in China
The collaboration will further utilize SteinCares’ reach as well as sales & marketing capabilities for maximum product accessibility in the region
Ref: PR Newswire | Image: BioThera
Related News:- Bio-Thera Solutions Receives the US FDA’s Approval for Tofidence (biosimilar, tocilizumab)
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
